RX&D Logo
☰

Innovative Medicines Canada
Code of Ethical Practices

Table of Contents Favourites News Events
  • Language: EN
    • EN EN
    • FR FR
?

  • Introduction
  • 1 - Guiding Principles
  • 2 - Privacy of Patient Information
  • 3 - Transparency
  • 4 - Members’ Employees
  • 5 - Scientific Exchanges
  • 6 - Business Meetings and Discussions
  • 7 - Retaining the Services of a Stakeholder
  • 8 - Consultant Meetings
  • 9 - Learning Programs for Health Care Professionals
  • 10 - Conferences and Congresses
  • 11 - Displays
  • 12 - Provision of Funding
  • 13 - Collaborations and Partnerships
  • 14 - Loan of Medical Equipment
  • 15 - Patient Support Programs and Medical Practice Activities
  • 16 - Service-Oriented Items
  • 17 - Clinical Evaluation Packages (“Samples”)
  • 18 - Market Research
  • 19 - Post Registration Clinical Studies
  • 20 - Enforcement
  • ANNEX A - Innovative Medicines Canada Guidelines for Transparency in Stakeholder Funding

My Favourites

  • 15.4 > Request for Support by Stakeholders remove
  • 3.1 > Transparency of product information remove
FavoriteLoadingClear favorites

News

  • IMC Statement on New Federal Government Task Force

Events


Sorry, can not connect to the events feed.
  • No items

PDf Page

X
Questions about this App? Please send us an email at
code@imc-mnc.ca.